stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) EPS (diluted)
MiniMed Group, Inc.'s EPS (diluted) for fiscal 2026 was −$1.29, compared with −$0.84 in fiscal 2025. Over the twelve months to 31 July 2026 it was −$0.59. MiniMed Group, Inc. ranks 33rd of 47 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | −$1.29 | — |
| FY2025 | −$0.84 | — |
| FY2024 | −$0.42 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jul 2026 | $0.00 | — |
| Jan 2026 | −$0.47 | — |
| Jul 2025 | −$0.08 | — |
| Jan 2025 | −$0.04 | — |
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NVST Envista Holdings Corporation compare | $3.92 |
| MMSI Merit Medical Systems, Inc. compare | $2.66 |
| ICUI ICU Medical, Inc. compare | $2.39 |
| STVN Stevanato Group S.p.A. compare | $0.59 |
| ATRC AtriCure, Inc. compare | $0.30 |
| BLCO Bausch + Lomb Corporation compare | −$0.30 |
| MMED MiniMed Group, Inc. | −$0.59 |
| PLSE Pulse Biosciences, Inc compare | −$1.21 |
| TFX Teleflex Incorporated compare | −$23.29 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on MMED
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement